Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Mol Neurobiol. 2018 Nov 20;56(7):5032–5040. doi: 10.1007/s12035-018-1430-0

Figure 2. PRF-P treatment does not contribute to the glioma cellular environment.

Figure 2.

a. Sample of the density plot representing brain cellular environment of glioma-bearing mice with and without PRF-P treatment derived from the blood of C57BL/6 congenic CD45.1 mice. b. Quantification of the total CD45.1+ cellularity in brains of glioma-bearing mice (n=5). c. Example of flow cytometry density plot showing gating strategy employed in quantification of: d. myeloid and e. microglia (n=5) immunological compartments. f. and g. Gating strategy used for the analysis of the CD3+ cells of the host and PRF-P origin in brains of glioma-bearing animals. h. Quantification of brain T cell types (CD4 and CD8) derived from the transplanted PRF-P (n=5).